Clinical Trial Update: Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of Lumasiran in healthy adults and patients with Primary Hyperoxaluria Type 1 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• Lumasiran (lumasiran)

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Primary Hyperoxaluria Type 1 (PH1) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-30